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INTRODUCTION
Chronic kidney disease and its final stage, irreversible renal insufficiency (end-stage renal dis-ease, ESRD) are recognised as a worldwide public health concern (health as well as economic Milorad Grujičić 1,2 , Milan Žigić 2,3 , Milanko Maksić 2,4 , Slobodan Hajder 3 , Darko Golić 2,5 , Branislav Gašić, Dragan Rakanović 5 , Novak Vasić 2,4 , Nataša Laganin 3 , Zoran Roljić 4 , Ljubomir Stajčić 6 , Mirjana Mišković 7 , Dubravka Mićić-Zrnić 1 , Goran Topić 1 , Vlado Đajić 8 METHODS problem), after taking into account the annual costs of treatment per patient 1 . Kidney transplantation is the preferred treatment for most patients with ESRD, since transplanted patients have significantly better quality of life and increased life expectancy, as shown in several clinical trials [2] [3] [4] [5] .
During the past 20 years, major changes have occurred in the Southeastern European countries regarding the area of kidney transplantation, as well as transplantation of other organs and tissues. Slovenia became a fully fledged member of Eurotransplant International Foundation in 2000, followed by Croatia in 2007. Besides, transplantation medicine was rapidly progressing in these countries, so that by 2011 Croatia reached the highest level of the donor rate (number of cadaveric organ donors per million population [p.m.p.]), and nowadays, Croatia is one of the leading countries in the world regarding the transplantation rate 6, 7 .
Another important step in the region that contributed to the development of the transplant programme in the Balkan region was the establishment of the At the beginning of 2010, a cooperation agreement in the field of transplantation was signed between the two clinical centres: the UCC RS and the MMA, where it was agreed that surgical and internist transplant teams would be working together at the UCC BL, in order to gradually train our doctors for independent transplantation. The first transplantation was performed in June 2010. Complete preparation of the donor and kidney recipient was performed at the UCC BL, and then the local surgical team (vascular surgeon, urologist), together with the MMA nephrologist, performed the renal transplantation at the UCC BL together with colleagues vascular surgeons, urologists, anesthesiologists, and nephrologists from the UCC BL. Post-operative monitoring and treatment of transplanted patients and donors was generally completed at the UCC BL.
Endpoints were patient and graft survival rates. Recipient's age, gender, induction immunosuppressive therapy, the underlying cause of ESRD, the dialysis modality and post-operative complications -surgical, medical, urinary tract infections (UTIs), electrolyte imbalance, graft rejection -and their influence on. 9 The standard immunosuppressive regimen included corticosteroids, calcineurin inhibitors (generally tacrolimus), and mycophenolate. In the maintenance therapy, in one patient, tacrolimus was replaced with cyclosporine due to diabetes and visual impairment, and in two patients RESULTS mycophenolate was replaced with azathioprine for planning pregnancy. Induction immunosuppressive therapy with basiliximab (Day 0 and Day 4) was given for the first two years in patients who had an increased immunological risk and, since 2013, in all patients.
A complete statistical analysis was performed using the statistical software PASW statistics 18. Attributed variables were presented as frequency of certain categories. Numerical variables were presented as mean with standard deviation. All the analyses were estimated at p<0.05 level of statistical significance. Unadjusted graft and patient survival rates were calculated using Kaplan-Meier plots and p-values derived from the univariate Log-rank test.
Clinical and other protocols related to research have been adhered to.
A total of 30 living-donor kidney transplantations were performed, 29 living-related donors and one living-unrelated donor renal transplantation. Preemptive kidney transplantation was performed in three patients (10%). In 27 patients renal transplantation was implemented after the onset of long-term dialysis. A total of 70% of kidney transplant recipients were male, and 30% of them were female. The average age of patients was 34.43 ± 8.67 years. The most common cause of ESRD was chronic glomerulonephritis -18 patients (60%) and other causes were hypertension, chronic pyelonephritis, vesicoureteral reflux (VUR), unknown underlying disease. Sociodemographic and clinical data were shown in Table 1 .
Complications after kidney transplantation are shown in Table 2 . The most common complications after kidney transplantation were UTIs (early-onset, late-onset or recurrent) -in 12 patients (40%); surgical complications were present in 10 patients (paralytic ileus -4, lymphocoele and perirenal hematoma -1 and surgical suture dehiscence and retained part of surgical drain in the abdominal cavity upon its removal -1). Except for patients with paralytic ileus and 1 patient with lymphocele who responded to the conservative treatment, others were successfully surgically treated, some of them were managed during transplantation.
Medical complications were present in 10 patients: hypertensive crisis -3, acute gastritis and new-onset diabetes mellitus -2 and negative drug interactions, fungal enterocolitis and drug-induced liver injury were observed in 1 patient.
Electrolyte imbalance (most commonly hypomagnesaemia or hypocalcaemia due to excessive post-operative polyuria) was present in six patients and was a likely cause of paralytic ileus. Graft rejection has occurred in five patients; a biopsy of the transplanted kidney was performed in two patients. Induction immunosuppressive therapy was administered to 23 (76.7%) patients. 
Survival Function
Overall survival of patients (days)
Yes No
Urinary tract infection: Figure 3 . Cumulative graft survival rates in the transplanted patients according to the incidence of postoperative urinary tract infections (UTIs). 
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Graft rejection: Kaplan-Maier curves of overall survival of patients and their grafts are given in Figures 1 and  2 , respectively.
One-, 3-, 5-and 8-year cumulative graft survival rates were 100%, 96.67%, 93.33% and 86.67%, respectively.
There was a statistically significant difference in the graft survival rates between the group of patients with or without UTIs (Figure 3) .
The graft survival rate in the group with UTIs was only 66.66%, in comparison with 100% into the group without UTIs.
There was also a statistically significant difference in the patient survival rates between the group of patients with no graft rejection (25 patients) and the group of patients with graft rejection ( Figure 4 ).
Overall patient survival was significantly lower in the group with graft rejection (60%) compared to the group without graft rejection (92%). The current mean value of glomerular filtration rate (GFR) in 25 patients with functional graft was 81.8 ± 30.3 mL/min (Table 3) .
One-, 3-, 5-and 8-year overall patient survival rates were 100%, 100%, 96.67% and 93.33%, respectively.
DISCUSSION
In the present study, the 1-, 3-, 5-and 8-year overall survival of the patient with a transplanted kidney, as well as the cumulative graft survival rates at specified time-points were monitored.
The impact of various factors on the graft survival, such as recipient's age, gender, induction immunosuppressive therapy, the underlying cause of ESRD, the dialysis modality and the post-operative complications (surgical, medical, UTIs, electrolyte imbalance, graft rejection) was also investigated.
Meta-analysis by Tonelli et al. 10 included 110 worldwide published studies with 1,961,904 patients who were on chronic haemodialysis or were transplanted; 79% of these studies showed that there was a statistically significantly higher mortality risk for dialysis patients (regardless of the dialysis modality) compared to transplanted patients; in the other 21% of studies that difference was not statistically significant.
In the study by Gondos et al. 11 13 the incidence of acute rejection in living-donor and cadaveric kidney transplantation was examined. Acute graft rejection was present in 44% of living-donor transplants and 28% of cadaveric transplants and was significantly more frequent (p <0.001) but there was no significant difference in graft survival rates for these groups.
Spanish authors Morales et al. 14 Two patients died: one due to a sepsis after massive pneumonia (with a functional graft) and the second one due to a stroke (developed 1.5 years after graft failure; Table 3 ). Three patients returned to dialysis after graft failure: one due to humoral rejection (proven by biopsy) that did not respond to the administered therapy, one due to vague thrombosis of the iliac artery and renal artery and one due to the unknown causes (with already present end-stage graft failure at the scheduled follow-up visit 1.5 year after kidney transplantation).
